Cafepharma | Pharmaceutical Sales, Medical Sales, Lab Sales

Cafepharma Today

December 8 2023 - In historic decision, FDA approves a CRISPR-based medicine for treatment of sickle cell disease

In historic decision, FDA approves a CRISPR-based medicine for treatment of sickle cell disease
FTC warns pharma companies on excessive drug patenting
Merck-Eisai's endometrial cancer therapy combo fails first-line treatment trial
Medtronic backs away from EOFlow deal
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Schering Leak Likely as Options Jumped

TheStreet.com

Tuesday, March 10, 2009 - 3:43pm

tags:

Schering Plough, Merck, buyouts

[video]Shareholders' next move and other pharma targets

Yahoo/Morningstar

Tuesday, March 10, 2009 - 3:42pm

tags:

Merck, Schering Plough, buyouts

Analysts say reluctant Lilly is merger candidate

Indianapolis Star, IN

Tuesday, March 10, 2009 - 10:33am

tags:

Eli Lilly, buyouts

Roche says latest Genentech bid is still fair

Yahoo/Reuters

Tuesday, March 10, 2009 - 10:31am

tags:

Genentech, Roche, buyouts

Eurand's ulcerative colitis drug candidate for children gets FDA orphan drug status

Yahoo/AP

Tuesday, March 10, 2009 - 10:30am

tags:

FDA, ulcerative colitis, Aptalis

New Wave of Pharma Mergers with Merck - Schering-Plough Deal

Seeking Alpha

Tuesday, March 10, 2009 - 9:28am

tags:

buyouts, Merck, Pfizer, Wyeth, Schering Plough

Three-Quarters of U.S. Health Plans Reimburse for Off-Label Uses of Prescription Drugs, According to Tufts Center for the Study of Drug Development

PR Inside

Tuesday, March 10, 2009 - 9:24am

tags:

[video]Mad About Options: Imagine Amgen

TheStreet.com

Tuesday, March 10, 2009 - 8:53am

tags:

As Cell Genesys shrinks, loss shrinks

Bizjournals.com

Tuesday, March 10, 2009 - 8:42am

tags:

Cell Genesys, Takeda, prostate cancer

Schering-Plough May Pay Off Before Merck’s Patent Losses Hurt

Bloomberg

Tuesday, March 10, 2009 - 8:40am

tags:

Merck, Schering Plough, pipelines, blood thinners, Singulair, JNJ

Eli Lilly granted request to halt generic launch of osteoporosis drug Evista in patent dispute

Yahoo/AP

Tuesday, March 10, 2009 - 8:39am

tags:

Evista, Eli Lilly, generics, Teva Pharmaceuticals

Big Pharma Consolidates as Bestselling Drugs Lose Patent Protection

Seeking Alpha

Tuesday, March 10, 2009 - 8:38am

tags:

patents, Big Pharma, Merck, Schering Plough

Arena Pharmaceuticals: Near Term Gamble May Be Worth It

Seeking Alpha

Tuesday, March 10, 2009 - 7:34am

tags:

Arena Pharmaceuticals, obesity, Qnexa, Vivus, Orexigen, Contrave, lorcaserin

Obama Plan to Copy Biotech Drugs May Get Early Push by Momenta

Bloomberg

Tuesday, March 10, 2009 - 7:33am

tags:

Obama, biotech, generics, Momenta, Lovenox, Sanofi

Ariad's partner Merck initiates Phase II lung cancer trial

Pharmaceutical Business Review

Tuesday, March 10, 2009 - 7:31am

tags:

Ariad Pharmaceuticals, Merck, drug trials, lung cancer, deforolimus

Forest's drug for Alzheimer's gets patent extension

Reuters

Tuesday, March 10, 2009 - 7:28am

tags:

Forest Labs, Alzheimer's disease, patents, Namenda

Genentech $112 Price Not Based on Realistic Outlook, Roche Says

Bloomberg

Tuesday, March 10, 2009 - 7:08am

tags:

Genentech, Roche, buyouts

Merck Deal Puts Pressure on AstraZeneca, Sanofi, J&J

Bloomberg

Tuesday, March 10, 2009 - 7:07am

tags:

Merck, buyouts, Schering Plough, Sanofi, JNJ, AstraZeneca

Obama Overturns Bush Policy on Stem Cell Research Funding

WSJ Online

Tuesday, March 10, 2009 - 7:06am

tags:

Obama, stem cells

Merck and the SEC: No Joke

Seeking Alpha

Tuesday, March 10, 2009 - 7:05am

tags:

Pages

Latest CP Wire Articles

First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study

Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth

Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Sapio Sciences launches new drug discovery platform

Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics

Why Medical and Pharma Sales Reps Should Start Their Own Senior Care Business

Bend Bioscience Adds Capacity and Technology Offerings with the Addition of New Process and Manufacturing Science Facility

Eastman introduces new excipient to formulate poorly soluble API

Most-clicked pharma news for week ending April 1 2023: Signify Health acquisition, Ferring Research Institute shutdown, Jardiance sales increase, and more

PharmaBlock Receives 2023 ACS CMO Excellence in Green Chemistry Award

Latest Pharmagather Articles

Transforming Medication Access with the Next Generation of Patient Support Services

Drug Channels

The Year in AdComms – A Look Back at 2023

eye on fda

What CVS Pharmacy’s New Cost-Plus Reimbursement Approach Means for PBMs, Pharmacies, Plan Sponsors, and Prescription Prices

Drug Channels

Drug Wholesalers and Brand-Name Drug Prices: Understanding CVS Health/McKesson and Why Pharmacies Lose Money on GLP-1s

Drug Channels

How Direct-to-Consumer Rx Platforms Help Patient Support Programs Succeed

Drug Channels

Drug Channels News Roundup, November 2023: My $0.02 on Express Scripts’ Cost-Based Pricing, Mark Cuban vs. PBMs, Dual-WAC Strategies, Pharmacy Shakeout, and Adam vs. Rocky

Drug Channels

Simplify and Accelerate Benefits Verification with a Fully Integrated, Adaptable Platform

Drug Channels

Medicare Part D in 2024: Mapping Large Chains' Position in 2024’s Preferred Pharmacy Networks

Drug Channels

Drug Channels Outlook 2024 (NEW Live Video Webinar)

Drug Channels